Bringing GCP to the Imaging Suite ™
MedQIA is a full service imaging CRO that specializes in cutting edge Quantitative Image Analysis for clinical trials. What sets us apart is our ability to develop and validate novel imaging biomarkers for use in global, regulated clinical trials.
Latest News
December 8, 2011 For Immediate Press Release: MedQIA Receives DHHS 501(k) Approval for Picture Archival and Communications System
MedQIA is announcing today the approval of its DHHS 501(k) application for integrated image analysis and data analysis system, known as IBIS: Imaging Biomarker Information System. IBIS provides data storage with full audit time stamp and e-signature capabilities. The IBIS … more
San Antonia Breast Cancer Symposium: MedQIA- not just a Prostate Cancer IRF
click here to view poster
San Antonio Breast Cancer Symposium: December 6-10, 2011
Henry B. Gonzalez Convention Center, San Antonio, Texas, USA… more
Recent R&D Presentation: Matthew Smith, M.D., Ph.D. Program Director: Genitourinary Oncology – Massachusetts General Hospital
“Very importantly in this investigator-sponsored trial, we used a prospectively defined definition of bone scan response using central review of bone scans in the computer assisted quantitative measurement by MedQIA. As you see here all of the patients had improvements … more
New Chapter Publication:computer-aided methods for early prediction of treatment response using diffusion-weighted MRI
“CADrx for GBM Brain Tumors: Predicting Treatment Response from Changes in Diffusion-Weighted MRI”
Authors: Jing Huo, Matthew Brown, Kazanuri Okada For details of the book see: http://www.igi-global.com/book/machine-learning-computer-aided-diagnosis/56023… more
All News
|
